Cure8 research brief
The study identifies and functionally validates a new STXBP3 variant that likely causes VEOIBD with immunodeficiency, which can help explain disease in affected infants and inform genetic counseling and further research.
Parents/caregivers of infants with VEOIBD, pediatric gastroenterologists, immunologists, geneticists, and researchers studying monogenic IBD
The authors performed trio whole-exome sequencing in an affected infant and found a previously undescribed splice-site change in STXBP3 that causes exon skipping and a truncated protein. Laboratory assays reported reduced binding between the abnormal STXBP3 protein and its partner STX4, supporting a functional effect.
The paper also summarizes clinical features from previously reported STXBP3 cases and notes possible differences in presentation by variant type (dominant splice/frameshift variants versus recessive missense variants), but the authors emphasize that the comparisons are preliminary because of small numbers.
Findings are based on a single new case plus a small literature review; proposed genotype–phenotype links are preliminary and require larger studies for confirmation.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Key Research and Development Program of China, award 2023YFC2706501; National Natural Science Foundation of China, award 82101953; Shanghai Rising-Star Program, award 22QA1401400; Science and Technology Innovation Plan Of Shanghai Science and Technology Commission, award 23Y11905100
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Genetic primary bile acid malabsorption can produce IBD-like symptoms and may be missed in children labeled with Crohn's disease; recognizing PBAM could change testing and management for some patients.
Finding neutralising anti-IL-10 antibodies in a subset of children with IBD may help explain why some patients have more severe, treatment‑resistant disease and points to a potential biomarker for risk stratification.
Imaging found increased visceral fat in children with Crohn's despite normal BMI, which could reveal inflammation-related risk not apparent from weight alone. Visceral adiposity was linked to markers of inflammation and...
